PCOS and Fertility: Your Complete Guide to Understanding and Managing Polycystic Ovary Syndrome for Conception

Polycystic ovary syndrome (PCOS) is the most common hormonal disorder affecting women of reproductive age, diagnosed in 8 to 13% of women globally — though actual prevalence may be higher due to underdiagnosis. Despite its name and the word "polycystic," PCOS is primarily a hormonal and metabolic condition, not simply an ovarian problem. Understanding what PCOS is — and what it is not — is the essential first step toward managing it effectively on your path to parenthood.

What Is PCOS? Understanding the Diagnosis

PCOS is diagnosed using the Rotterdam criteria, which require at least two of the following three features:

Oligo- or anovulation: Irregular or absent menstrual cycles, indicating infrequent or absent ovulation. For fertility, this is the most directly relevant criterion.

Clinical or biochemical signs of hyperandrogenism: Elevated levels of androgens (male-type hormones) manifesting as excess facial or body hair (hirsutism), acne, or male-pattern hair thinning. Blood tests showing elevated testosterone or DHEA-S confirm biochemical hyperandrogenism.

Polycystic ovarian morphology: Ultrasound showing 20 or more follicles per ovary, or ovarian volume greater than 10 mL — the "pearl necklace" pattern of small follicles that gave the condition its name. Notably, the presence of follicles does not mean they contain eggs ready for fertilisation; they are typically immature follicles that have stalled in development.

It is important to understand that a diagnosis of PCOS does not mean you cannot conceive. Many women with PCOS do conceive, some without assistance. The core challenge is typically irregular or absent ovulation — a problem that is often treatable.

The Hormonal Mechanisms Behind PCOS

The hormonal disruptions in PCOS form an interconnected web. Understanding them helps make sense of why treatments work — and why lifestyle interventions can be as powerful as medications.

Insulin resistance: The majority of women with PCOS — estimated at 50 to 80% — have some degree of insulin resistance, even those who are of normal weight. When cells become resistant to insulin's signalling, the pancreas compensates by producing more insulin. Elevated insulin directly stimulates the ovaries and adrenal glands to produce excess androgens.

Elevated androgens: High androgen levels disrupt follicle development. Instead of one dominant follicle maturing to ovulation, many small follicles begin developing but stall — creating the characteristic "polycystic" ultrasound appearance. Androgens also convert to oestrogen in fat tissue, further disrupting the hormonal balance that governs the menstrual cycle.

LH to FSH imbalance: Women with PCOS typically have an elevated LH to FSH ratio. This imbalance further impairs normal follicle development and ovulation. It also drives androgen production from the ovaries.

Chronic low-grade inflammation: PCOS is associated with elevated inflammatory markers, which contribute to insulin resistance and androgen overproduction. Inflammation also affects egg quality and uterine receptivity.

PCOS and Fertility: The Real Picture

The primary fertility challenge in PCOS is anovulation — cycles in which no egg is released. Without ovulation, conception is impossible, no matter how well-timed intercourse is. However, several important points provide perspective:

PCOS is the most treatable cause of anovulatory infertility. With appropriate intervention, the majority of women with PCOS can achieve ovulation and conception. The NHS reports that most women with PCOS who receive fertility treatment go on to have successful pregnancies.

PCOS does not necessarily affect egg quality in the same way as age-related decline. Women with PCOS often have large numbers of antral follicles and high AMH levels — signs of good ovarian reserve. The challenge is getting those follicles to fully develop and release their eggs.

Women with PCOS are at higher risk of certain pregnancy complications, including gestational diabetes, preeclampsia, and preterm birth. This underscores the importance of optimising metabolic health — particularly insulin sensitivity — before conception.

Lifestyle Interventions: The Underestimated Power of Diet and Exercise

For women with PCOS, lifestyle modification is not a consolation prize or a warm-up for "real" treatment — it is a primary and powerful therapeutic tool. Even modest improvements in insulin sensitivity can restore ovulation and dramatically improve fertility outcomes.

Diet: A low glycaemic index (GI) diet reduces insulin spikes and improves insulin sensitivity. The Mediterranean dietary pattern — rich in vegetables, legumes, whole grains, olive oil, fish, and nuts — has strong evidence for improving PCOS outcomes. Reducing processed carbohydrates, sugar, and refined foods directly addresses the insulin resistance that drives much of the hormonal disruption in PCOS.

A randomised controlled trial published in Clinical Endocrinology found that a low-GI diet improved menstrual cyclicity in women with PCOS more effectively than a conventional healthy eating diet, even without weight loss.

Weight management: In women with PCOS who are overweight, a weight loss of just 5 to 10% of body weight can restore regular ovulation and significantly improve fertility outcomes. This is not about achieving an "ideal" weight — even modest, sustainable weight loss produces meaningful hormonal improvements. However, it is important to note that normal-weight women with PCOS also benefit from lifestyle intervention, even without weight loss.

Exercise: Both aerobic exercise and resistance training improve insulin sensitivity independently of weight loss. A meta-analysis in Human Reproduction Update found that exercise intervention significantly improved menstrual frequency, ovulation rates, and metabolic markers in women with PCOS. Even 150 minutes of moderate-intensity exercise per week produces measurable benefits.

Evidence-Based Supplements for PCOS

Several nutritional compounds have compelling evidence for improving hormonal balance, insulin sensitivity, and ovulation in PCOS:

Myo-inositol: This is the most extensively studied supplement for PCOS, and the evidence is remarkably consistent. Myo-inositol is a naturally occurring sugar alcohol that acts as an insulin sensitiser, improving cellular insulin signalling and reducing the downstream hormonal disruptions that cause anovulation. A meta-analysis in Reproductive Biology and Endocrinology found that myo-inositol supplementation (4,000 mg/day) significantly improved ovulation rate, menstrual regularity, and clinical pregnancy rates in women with PCOS compared to placebo. It also reduced androgen levels, improved LH/FSH ratios, and — in combination with FSH — improved egg quality in women undergoing IVF.

Vitamin D: Deficiency of vitamin D is extremely common in women with PCOS, and evidence suggests it plays a role in the hormonal disruptions of the condition. Vitamin D receptors are expressed in ovarian tissue, and vitamin D influences insulin signalling, androgen production, and inflammatory markers. A systematic review found that vitamin D supplementation in deficient women with PCOS improved insulin sensitivity, reduced testosterone levels, and improved menstrual regularity.

Omega-3 fatty acids: The anti-inflammatory effects of omega-3s are directly relevant to PCOS, where chronic low-grade inflammation contributes to insulin resistance and androgen overproduction. A 2022 meta-analysis found that omega-3 supplementation significantly reduced serum testosterone, LH/FSH ratio, fasting insulin, and inflammatory markers in women with PCOS.

NAC (N-acetyl cysteine): NAC is an antioxidant precursor to glutathione with insulin-sensitising properties. Multiple clinical trials have found NAC to be as effective as metformin for improving insulin sensitivity and reducing androgen levels in PCOS. It is also associated with improved ovulation rates.

Chromium: Chromium picolinate improves insulin sensitivity and has shown benefit in small clinical trials for improving menstrual regularity and reducing testosterone in women with PCOS. It is often included as a supporting component alongside myo-inositol.

Medical Treatments for Ovulation Induction

When lifestyle changes and supplements are insufficient to restore regular ovulation, medical ovulation induction is highly effective for PCOS-related anovulatory infertility.

Letrozole: Now considered the first-line medication for ovulation induction in PCOS after a large multicentre trial found it superior to clomiphene for live birth rates. Letrozole is an aromatase inhibitor that temporarily reduces oestrogen levels, prompting a surge of FSH that stimulates follicle development. It is typically taken for 5 days at the beginning of the cycle.

Clomiphene citrate: A selective oestrogen receptor modulator that has been used for decades. While effective, it has a higher multiple pregnancy rate than letrozole and lower live birth rates in head-to-head trials. It may cause cervical mucus thickening and uterine lining thinning, which is why some specialists now prefer letrozole.

Metformin: An insulin sensitiser typically used for type 2 diabetes that also improves ovulation in PCOS by reducing insulin-driven androgen production. Particularly effective for PCOS patients with significant insulin resistance. Often used alone or in combination with letrozole.

Gonadotropin injections: Injectable FSH that directly stimulates follicle development. Requires careful monitoring by ultrasound due to the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy. Used when oral medications have failed.

Laparoscopic ovarian drilling (LOD): A surgical procedure that uses thermal energy to destroy androgen-producing ovarian tissue. Effective for restoring ovulation in women resistant to medication, with the advantage of single pregnancy births (unlike gonadotropins). Results typically last 6 to 12 months.

PCOS and IVF

When simpler interventions have not resulted in pregnancy, IVF is highly effective for PCOS. Women with PCOS typically have excellent responses to ovarian stimulation due to their large follicle pools. However, they are also at elevated risk of ovarian hyperstimulation syndrome (OHSS) — an overresponse to stimulation hormones that requires careful management.

Freeze-all strategies — where all embryos are frozen rather than fresh transferred — reduce OHSS risk and improve implantation rates by allowing the uterine lining to recover from stimulation medications. GnRH antagonist protocols and careful dose titration further reduce OHSS risk.

IVF success rates for PCOS are generally good, partly because of the large number of eggs typically retrieved.

Frequently Asked Questions

Conclusion

A PCOS diagnosis can feel like a significant obstacle on the path to parenthood. In reality, it is a manageable condition with well-established, effective treatment pathways. The hormonal disruptions that characterise PCOS — insulin resistance, elevated androgens, and anovulation — all respond to targeted intervention.

Start with lifestyle: a low-GI diet, regular exercise, and targeted supplementation with myo-inositol, vitamin D, and omega-3s. These changes alone restore regular ovulation in many women. If needed, ovulation induction medications are highly effective. Give yourself the time and the knowledge to navigate this journey well — and remember that the great majority of women with PCOS go on to achieve their family goals.